“The existing circumstance has exposed some structural weaknesses from the EU’s medicines supply chain and a large dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides explained. She recommended that offer chain problems be resolved in an EU pharmaceutical technique expe… Read More